Products/Services Used | Details | Operation |
---|---|---|
Molecular Biology Reagents> | To make VSV-G pseudotyped HIV-1 GFP, each T150 flask was transfected with 2.5 µg of vesicular stomatitis virus-G glycoprotein encoding plasmid (pMDG) (Genscript), 2.5 µg of packaging plasmid, p8.91 (encoding Gag-Pol, Tat and Rev) or p8.2 (encoding Gag-Pol, Tat and Rev and Vif, Vpr, Vpu and Nef) (Zufferey et al., 1997), and 3.75 µg of GFP encoding genome plasmid (pCSGW) using 30 µl Fugene 6 in 500µl optimum. | Get A Quote |
HIV-1 must replicate in cells that are equipped to defend themselves from infection through the intracellular innate immune system. Hence, HIV-1 evades innate immune sensing through encapsidated DNA synthesis and encodes accessory genes that antagonize specific antiviral effectors. Here we show that the HIV-1 Vpr protein antagonizes the stimulatory effect of a variety of pathogen associated molecular patterns, including cytoplasmic DNA, by inhibiting IRF3 and NF-κB nuclear transport. Both particle associated, and expressed Vpr, antagonized innate immune signaling. Phosphorylation of IRF3 at S396, but not S386, was also inhibited by Vpr. We provide evidence that Vpr interacts with karyopherins and disturbs thei... More